OSL signs agreement to distribute Low-level Laser Therapy Products

18th November 2024

OSL is thrilled to announce that we have signed an agreement to distribute Heltschl GmbH’s low-level laser therapy products in the UK and Ireland.

Formed in 1994, Heltschl GmbH is one of the leading suppliers of laser therapy devices in Austria and the neighbouring countries.

“It’s a great pleasure to have found such an expert and reliable partner in OSL for the distribution of our laser devices in the UK and Ireland in the field of oncology and radiotherapy. It is important for us to have a partner who can offer hospitals and patients the opportunity to provide an efficient form of therapy that reduces the side effects of chemotherapy and radiation therapy. We look forward to a successful collaboration and are excited about this expansion of our business activities” confirms Heltschl.

Low-level laser therapy can be used in almost all areas of medicine including oncology and radiation therapy, neurology, and veterinary medicine.

“Low-level laser therapy has been shown to be effective in the treatment of oral mucositis, offering the potential for significant improvement in the Quality of Life of head-and-neck patients. At OSL, we’re excited to be able to help increase access to this game-changing treatment to patients across the UK and Ireland” adds Lucy Griffiths, sales manager at OSL.

For more information, please reach out to OSL.